膀单胺转移抑制剂:当前的用途和未来的发展方向
Liana S Rosenthal1, Mena Farag2, N Ahmad Aziz3
1Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Lancet (London, England)
|August 9, 2025
概括
通过调节神经递质释放,膀单胺转运体2 (VMAT2) 抑制剂对于治疗运动和神经精神疾病至关重要. 由遗传学决定的个性化剂量可以提高VMAT2抑制剂的疗效和安全性.
科学领域:
- 神经科学
- 药理学
- 遗传学
背景情况:
- 膀单胺转运体2 (VMAT2) 在将神经递质包装到突触囊中起着至关重要的作用.
- VMAT2的失调与各种运动和神经精神疾病有关.
研究的目的:
- 审查用于治疗神经和精神疾病的VMAT2抑制剂的进展.
- 探索VMAT2在神经传递中的作用及其治疗含义.
主要方法:
- 对VMAT2抑制剂及其机制的最新文献的综述.
- 对高动力运动障碍的临床疗效分析.
- 对VMAT2抑制剂代谢的药物遗传影响的研究.
主要成果:
- 对于治疗亨廷顿病,晚期动力障碍和图雷特综合征,VMAT2抑制剂如四甲,二甲和瓦尔贝纳是有效的.
- 抑制剂调节神经递质的储存和释放,减少过度的突触活动.
- 遗传变异影响VMAT2抑制剂的代谢,需要个性化剂量.
结论:
- 在运动和神经精神疾病方面,VMAT2抑制剂具有显著的治疗效益.
- 药物遗传学可以通过精确医学优化治疗结果.
- 对VMAT2抑制的进一步研究可能会扩大神经和精神疾病的治疗应用.
更多相关视频
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
349
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
349
Drugs Affecting Neurotransmitter Release or Uptake
1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
880
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
880
Cholinergic Antagonists: Therapeutic Uses
873
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
873
Adrenergic Agonists: Indirect-Acting Agents
1.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.8K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
615
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
615


